IMUX Immunic, Inc.
Company Analysis
Latest News
🟢 Immunic is trading 5.2% up today on broad biotech strength and sector rebound
Immunic is trading at $14.08 (+5.15%) on broad biotech strength and a rebound from recent technical pressure. • The stock is tracking a 2.31% rally in the...
🔴 Immunic is trading 5.1% down today amid technical pressure and a cautious market
Immunic is trading 5.1% down at $13.55 today, driven by ongoing downside technical pressure and a cautious broader market sentiment. • The stock has faced...
🔴 Immunic is trading 5% down today amid biotech sector weakness and risk-off sentiment
Immunic is trading 5% down at $14.33 today, July 16, 2026, driven by broader biotech sector weakness and a shift toward risk-off sentiment in growth stocks. •...
🟢 Immunic is trading 5.2% up today on stock-specific strength despite a weak biotech tape
Immunic is trading 5.2% up at $15.40 on stock-specific strength, notably outperforming a broader downturn in the biotechnology sector. • There are no fresh...
🟢 Immunic is trading 6.97% up today in a technical rebound after recent profit-taking
Immunic is trading at $15.80 (6.97% up) in pre-market, staging a technical recovery following a 3.84% decline in the previous session. • The stock is...
🔴 IMUX is trading 5.3% down today on likely profit-taking
IMUX is trading 5.3% down today at $14.55 on likely profit-taking following yesterday’s outperformance versus a weak U.S. market. • No new earnings, clinical...
🟢 IMUX is trading 5% up today despite a lack of fresh catalysts
IMUX is trading 5% up today at $15.61 despite a lack of fresh company-specific catalysts, notably outperforming broadly weaker U.S. indices. • There are no...
🔴 IMUX is trading 5.1% down in pre-market after recent financing-related volatility
IMUX is trading at 5.1% down now at $14.06 in pre-market, extending a pullback after a sharp run-up tied to its large private placement financing and...
Immunic, Inc. Stockholders Approve Addition of 6 Million Shares to Equity Plan
Immunic, Inc. announced that at its annual meeting of stockholders on June 29, 2026, shareholders approved an amendment to the company's 2019 Omnibus Equity...
🟢 Immunic, Inc. is trading 5.5% up today, extending a multi-day rebound following analyst target updates
Immunic, Inc. is trading at $14.47 (+5.5%), extending a sharp multi-day rebound from levels near $12 seen earlier in June. • The move follows recent attention...
🟢 Immunic, Inc. is trading 5.9% up today, extending a sharp rebound from recent weakness
Immunic, Inc. is trading 5.9% up at $13.84, extending a sharp rebound that began earlier this week after prior weakness in the biotech and small-cap...
🟢 Immunic, Inc. is trading 10.1% up today on rebound after recent biotech and small-cap pressure
Immunic, Inc. is trading 10.1% up at $12.89 today as it rebounds from several down days and recent weakness in the biotech and small-cap sectors. • The stock...
🟢 Immunic, Inc. is trading 6.7% up today as shares rebound from recent pressure
Immunic, Inc. is trading 6.7% up at $12.49 as shares appear to be rebounding following recent biotech and small-cap pressure. • There are no fresh...
🔴 Immunic, Inc. is trading 5.3% down today as broad market sell-off pressures biotech
Immunic, Inc. is trading 5.3% down today at $11.61 as a broad risk-off environment pressures high-beta, small-cap biotech stocks. • The decline extends a...
🟢 Immunic, Inc. is trading 8.1% up today on a technical rebound after recent declines
Immunic, Inc. is trading 8.1% up at $13.25 in after-hours trading, rebounding from a recent multi-day slide. • The move appears driven by bargain hunting and...
🟢 Immunic, Inc. is trading 8.1% up today as it rebounds from recent weakness despite no clear catalyst
Immunic, Inc. is trading at $13.25 (8.1% up) in after-hours trading as the stock rebounds from recent weakness despite a lack of fresh company-specific...
🟢 Immunic, Inc. is trading 5.8% up today, rebounding from a two-day pullback amid broader market gains
Immunic, Inc. is trading at $12.76 (+5.76%), rebounding from a sharp two-day pullback despite a lack of company-specific news or regulatory updates. • The...
Immunic price target cut, yet analysts see massive 245% upside
Analysts revised the average one-year price target for Immunic, Inc. to $44.09 per share. This figure represents a 13.34% decrease from the previous estimate...
🔴 Immunic, Inc. is trading 0.1% down today amid biotech and rates-related volatility
Immunic, Inc. is trading at $12.78 (0.1% down) today amid ongoing biotech and rates-related volatility as investors digest recent sector-wide risk sentiment...
🔴 Immunic, Inc. is trading 0.1% down today amid broader biotech and rates-driven volatility
Immunic, Inc. is trading at $12.78 (0.1% down) in pre-market, remaining essentially flat versus the June 5 close of $12.77 following a period of high...